Grant of options

RNS Number : 6778O

Oncimmune Holdings PLC

08 November 2016

 

8 November 2016

Oncimmune Holdings plc

("Oncimmune" or the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND PERSONS CLOSELY ASSOCIATED WITH THEM

Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, today announces that on 8 November 2016, options over ordinary shares of the Company were awarded to certain Directors and certain PDMRs under the Company's 2016 Share Option Plan (an amalgamation of the Company's 2005 and 2007 Share Option Plans) as follows.

Name	Position	Number of share options awarded	Option exercise price per share (pence)	Percentage of issued share capital (%)
Meinhard Schmidt	Non-executive Chairman	120,370	108	0.236
Geoffrey Hamilton-Fairley	Chief Executive Officer	528,273	1	1.035
		119,875	108	0.235
Andrew Millet	Chief Financial Officer	92,593	108	0.181
Andrea Murray	Chief Operational Scientist	41,667	108	0.082
Maarten Brusse	Chief Commercial Officer	74,074	108	0.145

The options are subject to the rules of the 2016 Share Option Plan and vest in five equal annual parts, the first fifth vesting on 7 November 2017 and each year thereafter for a further four years, subject to continued employment. Unless otherwise indicated in the table above, the options are exercisable at 108 pence, being the mid-market closing price of the Company's ordinary shares on 7 November 2016

For further information:

Oncimmune Holdings plc

Geoffrey Hamilton-Fairley, Chief Executive Officer

[e-mail]

Zeus Capital Limited (Nominated Adviser and Broker)

Phil Walker, Giles Balleny, Dominic Wilson

[phone]

Media enquiries:

Consilium Strategic Communications

Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey Neville

[e-mail]

[phone]

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Meinhard Schmidt
2	Reason for the notification
a)	Position/status	Non-Executive Chairman, Director
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	options over 1p ordinary shares - 2016 Share Option Plan ISIN GB00BYQ94H38
b)	Nature of the transaction	Grant of options over ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) N/A 120,370
d)	Aggregated information	Price(s) Volume(s) N/A 120,370
e)	Date of the transaction	8 November 2016
f)	Place of the transaction	N/A

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Geoffrey Hamilton-Fairley
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings Plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	options over 1p ordinary shares - 2016 Share Option Plan ISIN GB00BYQ94H38
b)	Nature of the transaction	Grant of options over ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) N/A 528,273 N/A 119.875
d)	Aggregated information	Price(s) Volume(s)           N/A            648,148
e)	Date of the transaction	8 November 2016
f)	Place of the transaction	N/A

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Andrew Millet
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings Plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	options over 1p ordinary shares - 2016 Share Option Plan ISIN GB00BYQ94H38
b)	Nature of the transaction	Grant of options over ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) N/A 92,593
d)	Aggregated information	Price(s) Volume(s)         N/A             92,593
e)	Date of the transaction	8 November 2016
f)	Place of the transaction	N/A

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Andrea Murray
2	Reason for the notification
a)	Position/status	Chief Operational Scientist and PDMR
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings Plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	options over 1p ordinary shares - 2016 Share Option Plan ISIN GB00BYQ94H38
b)	Nature of the transaction	Grant of options over ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) N/A 41,667
d)	Aggregated information	Price(s) Volume(s)         N/A             41,667
e)	Date of the transaction	8 November 2016
f)	Place of the transaction	N/A

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Maarten Brusse
2	Reason for the notification
a)	Position/status	Chief Commercial Officer and PDMR
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings Plc
b)	LEI	N/A
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	options over 1p ordinary shares - 2016 Share Option Plan ISIN GB00BYQ94H38
b)	Nature of the transaction	Grant of options over ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) N/A 74,074
d)	Aggregated information	Price(s) Volume(s)         N/A             74,074
e)	Date of the transaction	8 November 2016
f)	Place of the transaction	N/A

 

END

 

 

DSHBIBDBSDGBGLI